Skip to main content

Table 3 Recovery of 12 ng/mL of bPL added to five foetal samples (A to E) in the presence of different dilutions of rabbit anti-bPL.

From: Effect of exogenous circulating anti-bPL antibodies on bovine placental lactogen measurements in foetal samples

Initial serum: bPL (ng/mL)

Identification of foetal sample

Foetal bPL concentrations (ng mL-1) and percentage of recovery

  

Rabbit anti-bPL dilutions

  

1:1,280,000

1:320,000

1:80,000

1:20,000

1:5,000

1:2,500

A: 8.9 ± 1.6

A+

8.6

7.5

3.7

2.6

1.6

0.7

 

A*

20.6

19.5

15.7

14.6

13.6

12.7

 

A++

20.5

19.0

13.9

11.3

6.9

5.4

 

Recovery (%)

99.4

97.4

88.3

77.3

50.4

42.9

B: 10.0 ± 1.3

B+

11.5

7.6

6.3

6.0

1.5

0.7

 

B*

23.5

19.6

18.3

18.0

13.5

12.7

 

B++

23.9

18.4

17.2

14.9

8.1

6.3

 

Recovery (%)

101.7

93.9

93.9

82.7

60.2

49.1

C: 17.5 ± 1.4

C+

18.1

19.4

15.4

16.4

3.3

0.9

 

C*

30.1

31.4

27.4

28.4

15.3

12.9

 

C++

29.5

28.5

23.8

20.7

10.7

5.3

 

Recovery (%)

98.1

90.8

87.1

72.8

70.1

41.4

D: 18.5 ± 1.9

D+

20.3

21.0

14.6

12.4

6.6

0.9

 

D*

32.3

33.0

26.6

24.4

18.6

12.9

 

D++

31.5

30.9

24.4

19.5

10.5

5.9

 

Recovery (%)

97.3

93.7

91.6

80.0

56.5

45.7

E: 21.3 ± 1.5

E+

22.56

19.3

21.2

15.3

5.2

1.2

 

E*

34.56

31.3

33.2

27.3

17.2

13.2

 

E++

35.60

28.8

30.6

20.2

11.2

6.3

 

Recovery (%)

103.01

92.2

92.2

74.1

64.8

47.7

  1. +: Concentrations of bPL in the presence of different dilutions of rabbit anti-bPL;
  2. *: Theoretical bPL concentrations after addition of 12 ng/mL of bPL;
  3. ++: Observed bPL concentration.